Chung-Min Tsai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chung-Min Tsai has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Hsi Chang
Department of Pediatrics Taipei Medical University Hospital Taipei Taiwan
5 shared publications - Shwu-Fen Chang
Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
4 shared publications Chun-Yin Hou
Department of Family Medicine, Taipei City Hospital, Taipei, Taiwan
2 shared publicationsBing-Chun Liou
1 shared publication- Chih-Chuan Li
Taipei Medical University Hospital, Department of Pediatrics, Taipei
1 shared publication Ching-Hua Su
1 shared publication
Latest Publications
- Open Access
- 25 March 2022
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 9 (01) , 015006-14
Transcranial photobiomodulation (808 nm) attenuates pentylenetetrazole-induced seizures by suppressing hippocampal neuroinflammation, astrogliosis, and microgliosis in peripubertal rats
Treatment of pediatric epilepsy relies on antiepileptic drugs (AEDs), but the response rates to AEDs are to 76%.1 New effective and noninvasive treatments for AED-refractory pediatric epilepsy are critically needed. Transcranial photobiomodulation (tPBM) with near-infrared (NIR) light refers to applying NIR transcranially according to the principle of photobiomodulation (PBM, previously termed low-level laser therapy).2 The mechanism of tPBM is based on photon absorption by mitochondrial cytochrome c oxidase (CCO).3 PBM has been studied in neurological diseases for 30 years.4 We recently demonstrated that tPBM (808 nm) attenuates seizures and status epilepticus (SE) induced by pentylenetetrazole (PTZ) in peripubertal rats.5 The behavioral and histopathological results showed that the treatment accomplished this (i) by reducing neuronal damage in the cortex, hippocampus (both GABAergic interneurons and principal cells), thalamus, and hypothalamus; (ii) by protecting hippocampal parvalbumin-positive interneurons—GABAergic interneurons that powerfully inhibit principal cells but are vulnerable to SE-induced apoptosis—from SE-induced apoptosis;6 and (iii) by preserving the integrity of the PV-immunoreactive perisomatic neuronal network surrounding the principal cells.7 Vogel et al.8 further revealed that repetitive tPBM (780 nm) reduced epileptiform discharges in a rat model of stroke-induced epilepsy. Regarding neuroprotection, tPBM has shown effects in reducing neuroinflammatory cytokines,7,9 which along with neuron-specific enolase (NSE) increased in the hippocampus after convulsive status epilepticus (CSE).10,11- 25 March 2022
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 9 (01) , 015006-14
Open AccessTranscranial photobiomodulation (808 nm) attenuates pentylenetetrazole-induced seizures by suppressing hippocampal neuroinflammation, astrogliosis, and microgliosis in peripubertal rats
Treatment of pediatric epilepsy relies on antiepileptic drugs (AEDs), but the response rates to AEDs are to 76%.1 New effective and noninvasive treatments for AED-refractory pediatric epilepsy are critically needed. Transcranial photobiomodulation (tPBM) with near-infrared (NIR) light refers to applying NIR transcranially according to the principle of photobiomodulation (PBM, previously termed low-level laser therapy).2 The mechanism of tPBM is based on photon absorption by mitochondrial cytochrome c oxidase (CCO).3 PBM has been studied in neurological diseases for 30 years.4 We recently demonstrated that tPBM (808 nm) attenuates seizures and status epilepticus (SE) induced by pentylenetetrazole (PTZ) in peripubertal rats.5 The behavioral and histopathological results showed that the treatment accomplished this (i) by reducing neuronal damage in the cortex, hippocampus (both GABAergic interneurons and principal cells), thalamus, and hypothalamus; (ii) by protecting hippocampal parvalbumin-positive interneurons—GABAergic interneurons that powerfully inhibit principal cells but are vulnerable to SE-induced apoptosis—from SE-induced apoptosis;6 and (iii) by preserving the integrity of the PV-immunoreactive perisomatic neuronal network surrounding the principal cells.7 Vogel et al.8 further revealed that repetitive tPBM (780 nm) reduced epileptiform discharges in a rat model of stroke-induced epilepsy. Regarding neuroprotection, tPBM has shown effects in reducing neuroinflammatory cytokines,7,9 which along with neuron-specific enolase (NSE) increased in the hippocampus after convulsive status epilepticus (CSE).10,11 - Open Access
- 21 March 2022
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 22 (1) , 1-15
Transcranial photobiomodulation add-on therapy to valproic acid for pentylenetetrazole-induced seizures in peripubertal rats
Background: Convulsive status epilepticus (CSE) prevention is critical for pediatric patients with epilepsy. Immediate intervention before CSE reduce severity. Despite its wide usage as an anticonvulsant, valproic acid (VPA) results in harmful side effects such as dose-dependent hepatotoxicity. Hence, reducing VPA dosage to minimize side effects while maintaining its efficacy is necessary, and transcranial photobiomodulation (tPBM) add-on therapy could facilitate this. We recently demonstrated for the first time that tPBM at a wavelength of 808 nm attenuated CSE in peripubertal rats. However, the effects of VPA with the add-on therapy of tPBM prior to seizures have not yet been explored. This study investigated whether adding tPBM to VPA exerts synergistic effect for CSE prevention in peripubertal rats.Methods: A gallium-aluminum-arsenide laser (wavelength of 808 nm with an exposure duration of 100 s and irradiance of 1.333 W/cm2at the target) was applied transcranially 30 min after VPA injection in Sprague Dawley rats. All the rats received 90 mg/kg of pentylenetetrazole (PTZ). Except for the saline (n = 3), tPBM + saline (n = 3), and PTZ group (n = 6), all the rats received a PTZ injection 30 min after VPA injection. The rats received add-on tPBM with PTZ immediately after tPBM. In the VPA + PTZ group, the rats received low-dose (100 mg/kg,n = 6), medium-dose (200 mg/kg,n = 6), and high-dose (400 mg/kg,n = 7) VPA. In the VPA + tPBM + PTZ group, the rats received low (100 mg/kg,n = 5), medium (200 mg/kg,n = 6), and high (400 mg/kg,n = 3) doses of VPA. Seizures were evaluated according to the revised Racine’s scale in a non-blinded manner.Results: Adding tPBM to low-dose VPA reduced the incidence of severe status epilepticus and significantly delayed the latency to stage 2 seizures. However, adding tPBM to high-dose VPA increased the maximum seizure stage, prolonged the duration of stage 4–7 seizures, and shortened the latency to stage 6 seizures.Conclusions: Adding tPBM to low-dose VPA exerted a synergistic prevention effect on PTZ-induced seizures, whereas adding tPBM to high-dose VPA offset the attenuation effect.
- 21 March 2022
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 22 (1) , 1-15
Open AccessTranscranial photobiomodulation add-on therapy to valproic acid for pentylenetetrazole-induced seizures in peripubertal rats
Background: Convulsive status epilepticus (CSE) prevention is critical for pediatric patients with epilepsy. Immediate intervention before CSE reduce severity. Despite its wide usage as an anticonvulsant, valproic acid (VPA) results in harmful side effects such as dose-dependent hepatotoxicity. Hence, reducing VPA dosage to minimize side effects while maintaining its efficacy is necessary, and transcranial photobiomodulation (tPBM) add-on therapy could facilitate this. We recently demonstrated for the first time that tPBM at a wavelength of 808 nm attenuated CSE in peripubertal rats. However, the effects of VPA with the add-on therapy of tPBM prior to seizures have not yet been explored. This study investigated whether adding tPBM to VPA exerts synergistic effect for CSE prevention in peripubertal rats.Methods: A gallium-aluminum-arsenide laser (wavelength of 808 nm with an exposure duration of 100 s and irradiance of 1.333 W/cm2at the target) was applied transcranially 30 min after VPA injection in Sprague Dawley rats. All the rats received 90 mg/kg of pentylenetetrazole (PTZ). Except for the saline (n = 3), tPBM + saline (n = 3), and PTZ group (n = 6), all the rats received a PTZ injection 30 min after VPA injection. The rats received add-on tPBM with PTZ immediately after tPBM. In the VPA + PTZ group, the rats received low-dose (100 mg/kg,n = 6), medium-dose (200 mg/kg,n = 6), and high-dose (400 mg/kg,n = 7) VPA. In the VPA + tPBM + PTZ group, the rats received low (100 mg/kg,n = 5), medium (200 mg/kg,n = 6), and high (400 mg/kg,n = 3) doses of VPA. Seizures were evaluated according to the revised Racine’s scale in a non-blinded manner.Results: Adding tPBM to low-dose VPA reduced the incidence of severe status epilepticus and significantly delayed the latency to stage 2 seizures. However, adding tPBM to high-dose VPA increased the maximum seizure stage, prolonged the duration of stage 4–7 seizures, and shortened the latency to stage 6 seizures.Conclusions: Adding tPBM to low-dose VPA exerted a synergistic prevention effect on PTZ-induced seizures, whereas adding tPBM to high-dose VPA offset the attenuation effect.
- Open Access
- 2 August 2020
- Published by Wiley in Journal of Biophotonics
- Vol. 13 (8)
Inside Cover
Transcranial photobiomodulation (tPBM) with wavelength at 808 nm was applied to a rat model of acute seizures. The tPBM successfully attenuated convulsive status epilepticus, and the tPBM was shown to reduce the apoptosis of parvalbumin‐positive interneurons (PV‐INs) and preserved the integrity of perisomatic inhibitory network of PV‐INs to principle cells in the hippocampus.Further details can be found in the article by Chung‐Min Tsai, Shwu‐Fen Chang, and Hsi Chang (e202000095). image
- 2 August 2020
- Published by Wiley in Journal of Biophotonics
- Vol. 13 (8)
Open AccessInside Cover
Transcranial photobiomodulation (tPBM) with wavelength at 808 nm was applied to a rat model of acute seizures. The tPBM successfully attenuated convulsive status epilepticus, and the tPBM was shown to reduce the apoptosis of parvalbumin‐positive interneurons (PV‐INs) and preserved the integrity of perisomatic inhibitory network of PV‐INs to principle cells in the hippocampus.Further details can be found in the article by Chung‐Min Tsai, Shwu‐Fen Chang, and Hsi Chang (e202000095). image
- Open Access
- 1 July 2020
- Published by Elsevier in Medical Hypotheses
- Vol. 140, 109685
AqF026 may act as a cancer therapeutic agent via inducing cancer cell oncosis
- 1 July 2020
- Published by Elsevier in Medical Hypotheses
- Vol. 140, 109685
Open AccessAqF026 may act as a cancer therapeutic agent via inducing cancer cell oncosis
- Open Access
- 3 May 2020
- Published by Wiley in Journal of Biophotonics
- Vol. 13 (8) , e202000095
Transcranial photobiomodulation attenuates pentylenetetrazole‐induced status epilepticus in peripubertal rats
Convulsive status epilepticus is the most common neurological emergency in children. Transcranial photobiomodulation (tPBM) reverses elevated rodent neurotransmitters after status epilepticus (SE) yet whether tPBM can attenuate seizure behaviors remains unknown. Here, we applied near‐infrared laser at wavelength 808 nm transcranially to peripubertal Sprague‐Dawley rats prior to pentylenetetrazole (PTZ) injection. Hematoxylin‐eosin, immunofluorescence (IF) staining with anti‐parvalbumin (PV) and terminal deoxynucleotidyl transferase dUTP nick‐end labeling (TUNEL) assay after IF staining was performed. Behaviorally, tPBM attenuated the mean seizure score and reduced the incidence of SE and mortality. Histochemically, tPBM reduced dark neurons in the cortex, hippocampus, thalamus and hypothalamus, lessened the apoptotic ratio of parvalbumin‐positive interneurons (PV‐INs) and alleviated the aberrant extent of PV‐positive unstained somata of PCs in the hippocampus. Conclusively, tPBM attenuated PTZ‐induced seizures, SE and mortality in peripubertal rats and reduced PTZ‐induced neuronal injury, apoptosis of PV‐INs and preserved PV positive perisomatic inhibitory network in the hippocampus.
- 3 May 2020
- Published by Wiley in Journal of Biophotonics
- Vol. 13 (8) , e202000095
Open AccessTranscranial photobiomodulation attenuates pentylenetetrazole‐induced status epilepticus in peripubertal rats
Convulsive status epilepticus is the most common neurological emergency in children. Transcranial photobiomodulation (tPBM) reverses elevated rodent neurotransmitters after status epilepticus (SE) yet whether tPBM can attenuate seizure behaviors remains unknown. Here, we applied near‐infrared laser at wavelength 808 nm transcranially to peripubertal Sprague‐Dawley rats prior to pentylenetetrazole (PTZ) injection. Hematoxylin‐eosin, immunofluorescence (IF) staining with anti‐parvalbumin (PV) and terminal deoxynucleotidyl transferase dUTP nick‐end labeling (TUNEL) assay after IF staining was performed. Behaviorally, tPBM attenuated the mean seizure score and reduced the incidence of SE and mortality. Histochemically, tPBM reduced dark neurons in the cortex, hippocampus, thalamus and hypothalamus, lessened the apoptotic ratio of parvalbumin‐positive interneurons (PV‐INs) and alleviated the aberrant extent of PV‐positive unstained somata of PCs in the hippocampus. Conclusively, tPBM attenuated PTZ‐induced seizures, SE and mortality in peripubertal rats and reduced PTZ‐induced neuronal injury, apoptosis of PV‐INs and preserved PV positive perisomatic inhibitory network in the hippocampus.
- 4 April 2019
- Published by Springer Nature in Lasers in Medical Science
- Vol. 34 (9) , 1829-1839
A transient protective effect of low-level laser irradiation against disuse-induced atrophy of rats
Satellite cells, a population of skeletal muscular stem cells, are generally recognized as the main and, possibly, the sole source of postnatal muscle regeneration. Previous studies have revealed the potential of low-level laser (LLL) irradiation in promoting satellite cell proliferation, which, thereby, boosts the recovery of skeletal muscle from atrophy. The purpose of this study is to investigate the beneficial effect of LLL on disuse-induced atrophy. The optimal irradiation condition of LLL (808 nm) enhancing the proliferation of Pax7+ve cells, isolated from tibialis anterior (TA) muscle, was examined and applied on TA muscle of disuse-induced atrophy model of the rats accordingly. Healthy rats were used as the control. On one hand, transiently, LLL was able to postpone the progression of atrophy for 1 week through a reduction of apoptosis in Pax7−veMyoD+ve (myocyte) population. Simultaneously, a significant enhancement was observed in Pax7+veMyoD+ve population; however, most of the increased cells underwent apoptosis since the second week, which suggested an impaired maturation of the population. On the other hand, in normal control rats with LLL irradiation, a significant increase in Pax7+veMyoD+ve cells and a significant decrease of apoptosis were observed. As a result, a strengthened muscle contraction was observed. Our data showed the capability of LLL in postponing the progression of disuse-induced atrophy for the first time. Furthermore, the result of normal rats with LLL irradiation showed the effectiveness of LLL to strengthen muscle contraction in healthy control.
- 4 April 2019
- Published by Springer Nature in Lasers in Medical Science
- Vol. 34 (9) , 1829-1839
A transient protective effect of low-level laser irradiation against disuse-induced atrophy of rats
Satellite cells, a population of skeletal muscular stem cells, are generally recognized as the main and, possibly, the sole source of postnatal muscle regeneration. Previous studies have revealed the potential of low-level laser (LLL) irradiation in promoting satellite cell proliferation, which, thereby, boosts the recovery of skeletal muscle from atrophy. The purpose of this study is to investigate the beneficial effect of LLL on disuse-induced atrophy. The optimal irradiation condition of LLL (808 nm) enhancing the proliferation of Pax7+ve cells, isolated from tibialis anterior (TA) muscle, was examined and applied on TA muscle of disuse-induced atrophy model of the rats accordingly. Healthy rats were used as the control. On one hand, transiently, LLL was able to postpone the progression of atrophy for 1 week through a reduction of apoptosis in Pax7−veMyoD+ve (myocyte) population. Simultaneously, a significant enhancement was observed in Pax7+veMyoD+ve population; however, most of the increased cells underwent apoptosis since the second week, which suggested an impaired maturation of the population. On the other hand, in normal control rats with LLL irradiation, a significant increase in Pax7+veMyoD+ve cells and a significant decrease of apoptosis were observed. As a result, a strengthened muscle contraction was observed. Our data showed the capability of LLL in postponing the progression of disuse-induced atrophy for the first time. Furthermore, the result of normal rats with LLL irradiation showed the effectiveness of LLL to strengthen muscle contraction in healthy control.
- Open Access
- 1 March 2019
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (3) , 692-699
Multiple subependymal pseudocysts in neonates play a role in later attention deficit hyperactivity and autistic spectrum disorder
- 1 March 2019
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (3) , 692-699
Open AccessMultiple subependymal pseudocysts in neonates play a role in later attention deficit hyperactivity and autistic spectrum disorder
- 1 August 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1828 (8) , 1794-1801
Quantifying membrane permeability of amphotericin B ion channels in single living cells
- 1 August 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1828 (8) , 1794-1801
Quantifying membrane permeability of amphotericin B ion channels in single living cells